CultMed Test
Embryo competence from spent blastocyst culture medium, typically collected on day 5 — without removing cells from the embryo.
Explore CultMed →Molecular insight for IVF
Non-invasive embryo selection to improve IVF based on miRNA profiling
FETUS IVF INC is developing two complementary tests to help IVF clinics address two critical questions: which of the most viable embryos to transfer and when to transfer it.
Our current priority is CultMed Test, which analyzes microRNA signals in spent embryo culture medium to assess embryo competence without an embryo biopsy. Our complementary Success Test analyzes maternal blood plasma to assess biological readiness for implantation.
We are seeking IVF clinic partners to support sample collection and validation as we work toward an initial U.S. laboratory-developed testing service.
Our tests
Two complementary tests.
Increased chance of pregnancy with the first embryo transfer.
Molecular microRNA analysis combined with bioinformatic evaluation to guide embryo selection and transfer planning.
Success Test
Maternal readiness from peripheral blood plasma, developed to support transfer planning alongside embryo assessment.
Explore Success →Development principles
Non-invasive samplingMolecular information without an embryo biopsy.
Evidence-led validationEach test follows its own validation program.
Clinic collaborationDesigned with IVF and embryology workflows in mind.
For IVF clinics
Be among the first with an innovative approach
We are inviting IVF clinics and embryology laboratories to discuss sample collection for our validation program, with an immediate emphasis on CultMed Test.